Human Genome Epidemiology Literature Finder
Records 1 - 2 (of 2 Records) |
Query Trace: Vomiting and KIT[original query] |
---|
Second-line dovitinib (TKI258) in patients with FGFR2-mutated or FGFR2-non-mutated advanced or metastatic endometrial cancer: a non-randomised, open-label, two-group, two-stage, phase 2 study. The Lancet. Oncology 2015 Jun 16 (6): 686-94. Konecny Gottfried E, Finkler Neil, Garcia Agustin A, Lorusso Domenica, Lee Paula S, Rocconi Rodney P, Fong Peter C, Squires Matt, Mishra Kaushal, Upalawanna Allison, Wang Yongyu, Kristeleit Rebec |
Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis. The New England journal of medicine 2016 Jun 374 (26): 2530-41. Gotlib Jason, Kluin-Nelemans Hanneke C, George Tracy I, Akin Cem, Sotlar Karl, Hermine Olivier, Awan Farrukh T, Hexner Elizabeth, Mauro Michael J, Sternberg David W, Villeneuve Matthieu, Huntsman Labed Alice, Stanek Eric J, Hartmann Karin, Horny Hans-Peter, Valent Peter, Reiter Andre |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: